AstraZeneca’s AL Amyloidosis Drug Misses Phase 3 Mortality Endpoint

July 20, 2025

How Much is Being Invested in AI Drug Discovery in 2026?

March 8, 2026

Bristol Myers Postpones Important Alzheimer’s Psychosis Cobenfy Readout

December 4, 2025

Must Read

Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy

April 21, 2026

Roche Initiates Phase III Study of Elevidys Following EMA Feedback

April 21, 2026

Top 10 Pharma News Websites You Should Follow in 2026

April 19, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Travere’s Filspari becomes the first FDA-approved medication for FSGS

IDEAYA and Servier Report Phase 2/3 Trial Success for Darovasertib Combination in Uveal Melanoma

Revolution Meets Key Survival Goals With RAS Inhibitor In Important Trial

Tepezza Sales Dip Slightly as Subcutaneous Formulation Shows Late-Stage Efficacy

Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy

Keebler Raises $16 Million Series A to Advance AI-Based Risk Adjustment Platform

BMS and Bain Capital Launch Beeline Medicines with Autoimmune Pipeline Led by Afimetoran

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

Top 10 Pharma News Websites You Should Follow in 2026

How Are Life Sciences Companies Raising Capital in 2026?

Can AI Predict Regulatory Outcomes in Pharma and Biotech?

Market Access Challenges in Pharmaceuticals: Pricing, Policy, and Payer Pressure

Editor Picks

AstraZeneca’s AL Amyloidosis Drug Misses Phase 3 Mortality Endpoint

How Much is Being Invested in AI Drug Discovery in 2026?

Bristol Myers Postpones Important Alzheimer’s Psychosis Cobenfy Readout

Must Read

Lilly to Acquire Kelonia for Up to $7 Billion, Adding Phase 1 In Vivo CAR-T Therapy

Roche Initiates Phase III Study of Elevidys Following EMA Feedback

Top 10 Pharma News Websites You Should Follow in 2026

Hot Topics

About Us

Follow Us

Newsletter

Editor Picks

Must Read

Hot Topics

About Us

Follow Us